Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you.
I'm still concerned about further dilution. I'm pretty sure it's what is holding the price action down. I think (for now) they (being ETRM) are done diluting but I think others are fearful of more to come and because of that are staying away and of course articles by SA don't help either. That PDUFA date is pretty far away (previously referenced Dec date).
I think the company got exactly what it wanted - additional funds with minimal share price drop. Timing for THEM was perfect but I am not happy with it. I wanted to see this into the $2's by now.
Unfortunately it's that freaking shelf filing. I have no doubt...and irritated as all can be. Hopefully it gets some legs under it in a bit but for now - they are clearly getting cash. I just would have thought they'd be smarter about it and wait (let the price rise a bit).
I was making a weak reference joke. :( When I said nothing was happening then to "move along" (as in go on with your business) that is all.
I know there are a few others in this (and stuck like me). It sucks. I keep saying I should have known better but well.
So I do have hope that this will turn around just very bothered by how it has moved DOWN since getting approved. As all others that are involved with TLON, just venting some frustration.
The bummer part of this - and you can see it in almost everyone still holding...we all seem to go thru our frustration at times, then circle out of it, then come back to it and around we all go, until something happens.
hope - certainly not logic.
if you decide to dig into past posts...u will see. Am I not allowed to express a feeling or two?
Hopefully that is simple enough for ya.
;)
Very simple answer to that what will happen question is......
nothing...
(then said in cop voice)
"move along...
move along.
Nothing happening HERE."
But what I believe Ernie was commenting about originally, was in reference to a comment about the price not being able to go any lower than .40. Based on our past experiences every time they 'announce' they are out of money the price continues to drop. That is what I believe Ernie is commenting about. I happen to agree with those thoughts.
If nothing changes I see this dropping down further to the .30's and possibly more. Without some fundamental change from the current sop we drop more. This is languishing. I was hoping that it would hit .50 so I could bail. That didn't even happen. :( I am tired of this, I want to just put it away and forget about it but then after a month I think, hey check into TLON and see what is going on, blah blah blah., nothing - drop nothing drop. :(
Just for stupid history of myself, I've been holding this because the loss to me is just too much. I feel that at this point, I have to hold it. Either lose it all or get lucky. I'm rolling the dice at this point. Not because I want to but because I'm stuck in it. I have to. I (like others here) felt there was NO way that when this got approved that it could keep dropping like this. Well - f me for thinking that way.
I don't know the complete 'back story' to FCSC. I DO know that it came out that they were diluting INTO their approval. Everyone had been buying into the event I bought a month or two early (standard thinking on FDA approval) and was going to get out but had set my sell price about 10 cents too high. Basically I missed the boat. :(
I left it and never really looked back. My original response on this (the post that you replied to) was in response to another post by bmatt - think, saying that he's never seen a stock held down so low AFTER an FDA approval...so I listed FCSC. The whole story I don't know. I just got out of the crap and remember, to always be weary. I've seen a few instances of stocks selling or diluting INTO their approval dates. It seems to have started up over the last couple years (at least to me it has)...I'm no expert in fact I am STILL really learning about investing and such. As such I have been burnt a couple times as well as hit pretty good on quite a few approvals.
I'm concerned on this one. I bought in at the right time (around .50 cents), made a nice profit and sold by accident at $1.70 or so...like an IDIOT I chased it and bought back - thinking it was still on the rise. Well - so many months later I'm stuck in this biatch. I'm merely trying to get some of my loss back.
the chart looks good except ONE thing...there still is no volume there. Until some volume gets into this thing it will be easily manipulated.
For whatever reason the chart is showing an increase in volume over the last week(s). Would be nice to see things start moving up...stay tuned.
I feel like I'm banging the VOLUME drum but until volume picks up - nothing will change. :( This will easily be manipulated with low volume and it will not rise until volume picks up.
We are still VERY lacking in volume...until that kicks in this can all be very temporary. I'm not complaining...I much prefer to see this going up...I just want to see it KEEP going up.
Too hammers in a row...at least this is starting to end the day strong...the chart is looking better. Hopefully it can get a couple more 'good' days in. :)
I am no chart expert but these hammers are a positive. Just wish the volume was a little better.
Except the share price is still being 'pushed' down. :( I'm so frustrated here. I've broken my own trading rules...held on when my losses dropped past 7% then 10% then 20% - expecting exactly that this would be approved and now that it is - I'm still stuck holding onto a lame duck. I will be patient and see what happens over the next week or two...but I'm really close to cutting my losses and moving on.
Yes - this one (and most stocks) seem to slow down during the lunch hours. However looking at the chart - we seem to be holding steady!!! Sweet...that usually means a nice 'bump'. I hope 1.90 will hit. I'd like to see another strong finish.
Looks like TLON is raging back after the lunch break. :) It's possible to close + and if so, does that say how strong this is?? I'm impressed so far. Another day of some very high volume compared to the 'average'. I much prefer to see this close positive after this opening action and on a Friday - will tell us all that it's much stronger than we realize. If not - then it looks like just another healthy 'pullback'.
Nice - I just noticed this today:
NeoStem to Present at the Seventh Annual JMP Securities Healthcare Conference
07/10/2012 07:30:11 ET
NEW YORK, Jul 10, 2012 (GlobeNewswire via COMTEX News Network) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a cell therapy company, today announced that its CEO will present at the Seventh Annual JMP Securities Healthcare Conference on July 12, 2012.
The presentation will be webcast live and available to view at the following web address: http://wsw.com/webcast/jmp18/nbs/. The webcast will be archived for 90 days following the live presentation.
The Seventh Annual JMP Securities Healthcare Conference
-- Date: July 12, 2012, 2:30 PM EDT
-- Venue: The Peninsula, New York, NY
-- Presenter: Robin L. Smith, M.D., M.B.A., Chairman and CEO of NeoStem
About NeoStem, Inc.
NeoStem, Inc. ("we," "NeoStem" or the "Company") continues to develop and build on its core capabilities in cell therapy to capitalize on the paradigm shift that we see occurring in medicine. In particular, we anticipate that cell therapy will have a large role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. Our January 2011 acquisition of Progenitor Cell Therapy, LLC ("PCT") provides NeoStem with a foundation in both manufacturing and regulatory affairs expertise. We believe this expertise, coupled with our existing research capabilities and collaborations, will allow us to achieve our mission of becoming a premier cell therapy company. Our PCT subsidiary's manufacturing base is one of the few current Good Manufacturing Practices ("cGMP") facilities available for contracting in the burgeoning cell therapy industry. Amorcyte, LLC ("Amorcyte"), which we acquired in October 2011, is developing a cell therapy for the treatment of cardiovascular disease. Amorcyte's lead compound, AMR-001, represents NeoStem's most clinically advanced therapeutic and Amorcyte is enrolling patients for a Phase 2 trial to investigate AMR-001's efficacy in preserving heart function after a heart attack. We also expect to begin a Phase 1 clinical trial by 2012/2013 to investigate AMR-001's utility in arresting the progression of congestive heart failure and the associated comorbidities of that disease. Athelos Corporation ("Athelos"), which is approximately 80%-owned by our subsidiary, PCT, is engaged in collaboration with Becton-Dickinson that is exploring the earlier stage clinical development of a T-cell therapy for autoimmune conditions. In addition, our pre-clinical assets include our VSEL(TM) Technology platform as well as our MSC (mesenchymal stem cells) product candidate for regenerative medicine.
For more information on NeoStem, please visit www.neostem.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy, including with respect to the Company's successful development of cell therapeutics, as well as the future of the cell therapeutics industry. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 20, 2012 and in the Company's periodic filings with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: NeoStem Inc.
CONTACT: Trout Group
Gitanjali Jain Ogawa, Vice President
Phone: +1-646-378-2949
Email: gogawa@troutgroup.com
NeoStem, Inc.
Robin Smith, CEO
Phone: +1-212-584-4174
Email: rsmith@neostem.com
By Staff
(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
Yes...I see the volume but I'm NOT seeing the price. :( Moving into the lunch hours this stock tends to level off. I think we are at our 'closing' here...probably high .60's which I will take. I'd still prefer to see this climb to finish in the .70's today - we'll see if it picks up after lunch but the history doesn't play into that.
Wow - with this volume this should get into the .70's easy...here's to hoping that occurs and that it closes there. :)
I don't want a 'pop' I want to see a steady ascent. :( This is ridiculous. Sure - I got my ten cent RXII but that does NOT make up for the losses I've incurred. I wish I could cut and run...but that is my OWN fault.
Yeah interesting (not sure if i'd personally use that word) lol ...if nothing else it appears to be following a pattern and from what I see - it 'should' reverse soon - tomorrow or day after?
GIGM (1.47) -
Cj - I am trying to learn...what is a step by step 'buyback'?
Based on my interest you can figure that I'm in this one...and am curious as to what it's 'supposed' to do as part of my learning process. :)
Thanks,
bluemonstr
GIGM at ($1.29) and still climbing. Looks like some big buys just happened at 1.32.
I got in on this yesterday morning - its been on an uptrend since Oct. I'm not sure who originally posted it - but it looks like it's going up - as you mentioned Redlegs - there is some divided date set in Feb...I decided to play on that catalyst after I looked at the charts from a year ago. :)
this board rocks!
bluemonstr